Serum CEA Concentrations in Dogs with Primary and Metastatic Pulmonary Neoplasms: Comparison Among Clinical Groups and Association with Survival
Veterinary Sciences · 16.11.2026 · 13 (11) · 1233
DOI: 10.3390/vetsci13111233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 16.11.2026. Verfasst von Adilson Paulo Marchioni Cabral und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil.
Abstract (Originalsprache)
Carcinoembryonic antigen (CEA) is widely used as a tumour biomarker in human medicine, but its applicability in dogs with pulmonary neoplasms remains poorly defined. This retrospective study evaluated serum CEA concentrations in dogs with primary and metastatic pulmonary neoplasms. Thirty-seven dogs with stored serum available were allocated to four groups: G1, primary pulmonary neoplasms treated by lobectomy; G2, primary pulmonary neoplasms not treated surgically; G3, pulmonary metastases from mammary neoplasms; and G4, pulmonary metastases from other extrathoracic neoplasms. CEA was measured by ELISA at diagnosis (D0) and 30 days after the start of treatment (D30). Concentrations differed among groups at D0 (p = 0.023) and D30 (p = 0.004), being highest in G3. Receiver operating characteristic analysis yielded areas under the curve of 0.798 at D0 (cut-off ≥ 0.90 ng/mL; sensitivity, 69.2%; specificity, 83.3%) and 0.938 at D30 (cut-off ≥ 1.05 ng/mL; sensitivity, 90.9%; specificity, 100%). Higher CEA was associated with an increased risk of death when all dogs were analysed together. CEA shows potential as a complementary biomarker for identifying dogs with pulmonary metastases of mammary origin, whereas its value for early monitoring of therapeutic response and as an independent prognostic marker was limited.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil
Zitieren
APA
Cabral, A. P. M., Senhorello, I. L. S., Júnior, J. C. N. D. C., Cruvinel, G. G., Anai, L. A., & Nardi, A. B. D. (2026). Serum CEA Concentrations in Dogs with Primary and Metastatic Pulmonary Neoplasms: Comparison Among Clinical Groups and Association with Survival. Veterinary Sciences, 13(11), 1233. https://doi.org/10.3390/vetsci13111233
Vancouver
Cabral APM, Senhorello ILS, Júnior JCNDC, Cruvinel GG, Anai LA, Nardi ABD. Serum CEA Concentrations in Dogs with Primary and Metastatic Pulmonary Neoplasms: Comparison Among Clinical Groups and Association with Survival. Veterinary Sciences. 2026;13(11):1233. doi:10.3390/vetsci13111233
BibTeX
@article{Cabral2026,
author = {Cabral, Adilson Paulo Marchioni and Senhorello, Igor Luiz Salardani and Júnior, Júlio César Nascimento de Cerqueira and Cruvinel, Giovanna Gabrielle and Anai, Letícia Abrahão and Nardi, Andrigo Barboza De},
title = {Serum CEA Concentrations in Dogs with Primary and Metastatic Pulmonary Neoplasms: Comparison Among Clinical Groups and Association with Survival},
journal = {Veterinary Sciences},
year = {2026},
volume = {13},
number = {11},
pages = {1233},
doi = {10.3390/vetsci13111233}
}
EUVIMED